MTTLAB SRL
Desconocido
NeuroNanotech: Nanoplatforms for Neuroscience
MTTLAB SRL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
NeuroNanotech will train eleven researchers to tackle one of the major challenges in Europe’s ageing population - neurological diseases.
The...
2024-07-02 - 2028-12-31 | Financiado
2024-07-02 - 2028-12-31 | Financiado
SINERGIA: advanced technologieS for drug dIscovery and precisioN mEdicine in vitRo modellinG human physiology...
MTTLAB SRL
participó en un
H2020:
H2020-MSCA-ITN-2019
A key step in the drug development process is to predict information on safety, efficacy and mechanisms of action of a candidate molecule as...
2019-08-09 - 2024-02-29 | Financiado
2019-08-09 - 2024-02-29 | Financiado
* No se disponen de datos de la empresa actual.